{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:23Z","timestamp":1791644363298,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Natural killer\/T-cell lymphoma (NKTCL) is an aggressive haematological malignancy with poor prognosis, particularly in patients with relapsed\/refractory (R\/R) disease. The mechanisms underlying multidrug resistance in NKTCL remain unclear and present an urgent challenge that must be addressed during clinical treatment. Multidrug-resistant NKTCL models were established using adriamycin (ADM), and cellular senescence was confirmed by markers including P16, P21, and senescence-associated \u03b2-galactosidase (SA-\u03b2-gal). Proteomic sequencing of plasma from clinical patients and resistant cells identified LCP2 as a key protein. Phosphoproteomics, mass spectrometry, and co-immunoprecipitation analyses revealed LCP2\u2019s role in mediating senescence-associated chemoresistance. An in vivo ageing microenvironment model was used to assess whether targeting the LCP2-mediated axis could eliminate chemoresistant senescent cells. Results show that ADM-resistant NKTCL cells exhibited phenotypic and senescence features. Of these, LCP2 expression was significantly reduced in the plasma of R\/R NKTCL patients and in chemoresistant cells, correlating inversely with senescence marker SA-\u03b2-gal. Moreover, LCP2 knockdown enhanced the chemoresistance, senescent-associated secretory phenotype secretion, and G0\/G1 cell cycle arrest in NKTCL cells. Mechanistically, LCP2 deficiency activated the IQGAP2\/LaminA\/C\/SUV39H1 axis, thus driving DNA damage, telomere stress-induced senescence, and facilitating the formation of an immunosuppressive microenvironment. Importantly, targeting this axis with Epitalon and Chaetocin can partially eliminate therapy-induced senescent cells, enhance response to chemotherapeutics, and alleviate the immunosuppressive microenvironment to a certain extent in vivo. In conclusion, this study is the first to uncover LCP2 as a critical biomarker of senescence-related chemoresistance in NKTCL, providing a theoretical basis for the clinical translation of senolytics for treating R\/R NKTCL.<\/jats:p>","DOI":"10.1038\/s41419-026-08897-6","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:44:32Z","timestamp":1779986672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer\/T-cell lymphoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangzhuang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-551X","authenticated-orcid":false,"given":"Mingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-8189","authenticated-orcid":false,"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0025-7554","authenticated-orcid":false,"given":"Qingjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"8897_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-023-01483-9","volume":"16","author":"XP Tian","year":"2023","unstructured":"Tian XP, Cao Y, Cai J, Zhang YC, Zou QH, Wang JN, et al. Novel target and treatment agents for natural killer\/t-cell lymphoma. J Hematol Oncol. 2023;16:78.","journal-title":"J Hematol Oncol"},{"key":"8897_CR2","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","volume":"35","author":"H Wang","year":"2021","unstructured":"Wang H, Fu BB, Gale RP, Liang Y. NK-\/T-cell lymphomas. Leukemia. 2021;35:2460\u201368.","journal-title":"Leukemia"},{"key":"8897_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11899-018-0430-5","volume":"13","author":"R Suzuki","year":"2018","unstructured":"Suzuki R. NK\/T cell lymphoma: updates in therapy. Curr Hematol Malig Rep. 2018;13:7\u201312.","journal-title":"Curr Hematol Malig Rep"},{"key":"8897_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","volume":"15","author":"E Tse","year":"2022","unstructured":"Tse E, Zhao WL, Xiong J, Kwong YL. How we treat NK\/T-cell lymphomas. J Hematol Oncol. 2022;15:74.","journal-title":"J Hematol Oncol"},{"key":"8897_CR5","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","volume":"76","author":"M Yamaguchi","year":"1995","unstructured":"Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, et al. Frequent expression of p-glycoprotein\/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995;76:2351\u201356.","journal-title":"Cancer"},{"key":"8897_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaoncol.2022.1968","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang L, Liu X, Li X, Li L, Fu X, et al. Efficacy and safety of a pegasparaginase-based chemotherapy regimen vs an L-asparaginase-based chemotherapy regimen for newly diagnosed advanced extranodal natural killer\/T-cell lymphoma: a randomized clinical trial. JAMA Oncol. 2022;8:1035\u201341.","journal-title":"JAMA Oncol"},{"key":"8897_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/cts.12893","volume":"14","author":"X Wang","year":"2021","unstructured":"Wang X, Hu J, Dong M, Ding M, Zhu L, Wu J, et al. DDGP vs. SMILE in relapsed\/refractory extranodal natural killer\/T-cell lymphoma, nasal type: a retrospective study of 54 patients. Clin Transl Sci. 2021;14:405\u201311.","journal-title":"Clin Transl Sci"},{"key":"8897_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20:89\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"8897_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan D, Belenki D, Dabritz J, Zhao Z, Yu Y, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553:96\u2013100.","journal-title":"Nature"},{"key":"8897_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188994","volume":"1878","author":"T Saleh","year":"2023","unstructured":"Saleh T, Bloukh S, Hasan M, Al SS. Therapy-induced senescence as a component of tumor biology: evidence from clinical cancer. Biochim Biophys Acta Rev Cancer. 2023;1878:188994.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8897_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer-role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"8897_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0644-6","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Fu X, Dong M, Yang Z, Wu S, Ma M, et al. Conserved cell populations in doxorubicin-resistant human nasal natural killer\/T cell lymphoma cell line: super multidrug resistant cells? Cancer Cell Int. 2018;18:150.","journal-title":"Cancer Cell Int"},{"key":"8897_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s43587-024-00663-7","volume":"4","author":"S Zumerle","year":"2024","unstructured":"Zumerle S, Sarill M, Saponaro M, Colucci M, Contu L, Lazzarini E, et al. Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice. Nat Aging. 2024;4:1231\u201348.","journal-title":"Nat Aging"},{"key":"8897_CR14","doi-asserted-by":"publisher","first-page":"e009356","DOI":"10.1136\/jitc-2024-009356","volume":"13","author":"J Wang","year":"2025","unstructured":"Wang J, Tao Q, Huang K, Wang Y, Hu L, Ren A, et al. Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin\u2019s lymphoma via CCR7\/ARHGAP18\/IKB\u03b1 signaling activation. J Immunother Cancer. 2025;13:e009356.","journal-title":"J Immunother Cancer"},{"key":"8897_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41580-022-00483-w","volume":"23","author":"J Padeken","year":"2022","unstructured":"Padeken J, Methot SP, Gasser SM. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat Rev Mol Cell Biol. 2022;23:623\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8897_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243\u201378.","journal-title":"Cell"},{"key":"8897_CR17","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1016\/j.molcel.2024.08.006","volume":"84","author":"N Dasgupta","year":"2024","unstructured":"Dasgupta N, Lei X, Shi CH, Arnold R, Teneche MG, Miller KN, et al. Histone chaperone HIRA, promyelocytic leukemia protein, and p62\/SQSTM1 coordinate to regulate inflammation during cell senescence. Mol Cell. 2024;84:3271\u201387.","journal-title":"Mol Cell"},{"key":"8897_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102857","volume":"131","author":"VS Iyer","year":"2022","unstructured":"Iyer VS, Boddul SV, Johnsson AK, Raposo B, Sharma RK, Shen Y, et al. Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2. J Autoimmun. 2022;131:102857.","journal-title":"J Autoimmun"},{"key":"8897_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2885","volume":"4","author":"B Liu","year":"2013","unstructured":"Liu B, Wang Z, Zhang L, Ghosh S, Zheng H, Zhou Z. Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat Commun. 2013;4:1868.","journal-title":"Nat Commun"},{"key":"8897_CR20","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chu J, Hou Q, Qian S, Wang Z, Yang Q, et al. Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: from mechanisms to clinical therapy (review). Int J Oncol. 2024;64:5653.","DOI":"10.3892\/ijo.2024.5653"},{"key":"8897_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31504-z","volume":"13","author":"LL Niborski","year":"2022","unstructured":"Niborski LL, Gueguen P, Ye M, Thiolat A, Ramos RN, Caudana P, et al. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas. Nat Commun. 2022;13:3739.","journal-title":"Nat Commun"},{"key":"8897_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/2159-8290.CD-22-1319","volume":"14","author":"N Jain","year":"2024","unstructured":"Jain N, Zhao Z, Koche RP, Antelope C, Gozlan Y, Montalbano A, et al. Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function. Cancer Discov. 2024;14:142\u201357.","journal-title":"Cancer Discov"},{"key":"8897_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/QAD.0b013e32835535f5","volume":"26","author":"S Bouchat","year":"2012","unstructured":"Bouchat S, Gatot JS, Kabeya K, Cardona C, Colin L, Herbein G, et al. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients. Aids. 2012;26:1473\u201382.","journal-title":"Aids"},{"key":"8897_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.37","volume":"5","author":"YS Lai","year":"2015","unstructured":"Lai YS, Chen JY, Tsai HJ, Chen TY, Hung WC. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Blood Cancer J. 2015;5:e313.","journal-title":"Blood Cancer J"},{"key":"8897_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/neuonc\/noad222","volume":"26","author":"DE Xin","year":"2024","unstructured":"Xin DE, Liao Y, Rao R, Ogurek S, Sengupta S, Xin M, et al. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Neuro Oncol. 2024;26:735\u201348.","journal-title":"Neuro Oncol"},{"key":"8897_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41556-020-00589-3","volume":"22","author":"RI Martinez-Zamudio","year":"2020","unstructured":"Martinez-Zamudio RI, Roux PF, de Freitas J, Robinson L, Dore G, Sun B, et al. Author correction: AP-1 imprints a reversible transcriptional programme of senescent cells. Nat Cell Biol. 2020;22:1286\u201388.","journal-title":"Nat Cell Biol"},{"key":"8897_CR27","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ccell.2025.07.023","volume":"43","author":"RS Hesterberg","year":"2025","unstructured":"Hesterberg RS, Davis JT, Handoo KJ, Elmarsafawi AG, Augello AC, Cheng CH, et al. Lymphoma accelerates T cell and tissue aging. Cancer Cell. 2025;43:1917\u201336.e8.","journal-title":"Cancer Cell"},{"key":"8897_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57429-x","volume":"16","author":"D Belenki","year":"2025","unstructured":"Belenki D, Richter-Pechanska P, Shao Z, Bhattacharya A, Lau A, Nabuco LFDF, et al. Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control. Nat Commun. 2025;16:3079.","journal-title":"Nat Commun"},{"key":"8897_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3324\/haematol.2015.139154","volume":"101","author":"N Dezorella","year":"2016","unstructured":"Dezorella N, Katz BZ, Shapiro M, Polliack A, Perry C, Herishanu Y. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course. Haematologica. 2016;101:1553\u201362.","journal-title":"Haematologica"},{"key":"8897_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10875-022-01412-4","volume":"43","author":"A Lev","year":"2023","unstructured":"Lev A, Asleh M, Levy S, Lee YN, Simon AJ, Stepensky P, et al. SLP76 mutation associated with combined immunodeficiency and EBV-related lymphoma. J Clin Immunol. 2023;43:625\u201335.","journal-title":"J Clin Immunol"},{"key":"8897_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","volume":"13","author":"J Lian","year":"2020","unstructured":"Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13:151.","journal-title":"J Hematol Oncol"},{"key":"8897_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s42003-021-02089-y","volume":"4","author":"K Fukuda","year":"2021","unstructured":"Fukuda K, Shimura C, Miura H, Tanigawa A, Suzuki T, Dohmae N, et al. Regulation of mammalian 3D genome organization and histone H3K9 dimethylation by H3K9 methyltransferases. Commun Biol. 2021;4:571.","journal-title":"Commun Biol"},{"key":"8897_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46769-9","volume":"15","author":"D Maggiorani","year":"2024","unstructured":"Maggiorani D, Le O, Lisi V, Landais S, Moquin-Beaudry G, Lavallee VP, et al. Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nat Commun. 2024;15:2435.","journal-title":"Nat Commun"},{"key":"8897_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2147\/JHC.S296234","volume":"8","author":"M Wang","year":"2021","unstructured":"Wang M, Chen J, Song S, Su J, Zhao L, Liu Q, et al. Inhibition of SIRT1 limits self-renewal and oncogenesis by inducing senescence of liver cancer stem cells. J Hepatocell Carcinoma. 2021;8:685\u201399.","journal-title":"J Hepatocell Carcinoma"},{"key":"8897_CR35","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","volume":"37","author":"N Wang","year":"2025","unstructured":"Wang N, Lu S, Cao Z, Li H, Xu J, Zhou Q, et al. Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism. Cell Metab. 2025;37:1381\u201399.","journal-title":"Cell Metab"},{"key":"8897_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.devcel.2023.05.010","volume":"58","author":"M D\u2019Ambrosio","year":"2023","unstructured":"D\u2019Ambrosio M, Gil J. Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies. Dev Cell. 2023;58:1007\u201321.","journal-title":"Dev Cell"},{"key":"8897_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13948","volume":"22","author":"H Power","year":"2023","unstructured":"Power H, Valtchev P, Dehghani F, Schindeler A. Strategies for senolytic drug discovery. Aging Cell. 2023;22:e13948.","journal-title":"Aging Cell"},{"key":"8897_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.186344","volume":"10","author":"C Li","year":"2025","unstructured":"Li C, Xie Q, Ghosh S, Cao B, Du Y, Vo GV, et al. SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma. JCI Insight. 2025;10:e186344.","journal-title":"JCI Insight"},{"key":"8897_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(02)00090-3","volume":"183","author":"VN Anisimov","year":"2002","unstructured":"Anisimov VN, Khavinson VK, Popovich IG, Zabezhinski MA. Inhibitory effect of peptide epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Lett. 2002;183:1\u201308.","journal-title":"Cancer Lett"},{"key":"8897_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10522-025-10315-x","volume":"26","author":"S Al-Dulaimi","year":"2025","unstructured":"Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26:178.","journal-title":"Biogerontology"},{"key":"8897_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tcb.2022.04.011","volume":"33","author":"RL Cohn","year":"2023","unstructured":"Cohn RL, Gasek NS, Kuchel GA, Xu M. The heterogeneity of cellular senescence: insights at the single-cell level. Trends Cell Biol. 2023;33:9\u201317.","journal-title":"Trends Cell Biol"},{"key":"8897_CR42","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. IPROX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211\u201317.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08897-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:11:22Z","timestamp":1785517882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08897-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8897"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08897-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The animal experiments were conducted following ARRIVE guidelines. The experiment was approved by the Ethics Committee of Scientific Research and Clinical Trial of the First Affiliated Hospital of Zhengzhou University (approval no. 2023-KY-0843-002; Zhengzhou, China).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"662"}}